{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.54","value":"15.33"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"description":"Average number of days per patient for resolution of cytopenias.","dispersionType":"Standard Deviation","groups":[{"description":"All patients that received Basiliximab 20 mg monoclonal therapy","id":"OG000","title":"Basiliximab 20 mg"}],"paramType":"MEAN","populationDescription":"IIT: All patients that received study drug.","timeFrame":"From Day -1 (day before stem cell infusion) to Day +20 (20 days after stem cell infusion)","title":"Time to Resolution of Cytopenias: Platelet Transfusion Independence","type":"SECONDARY","unitOfMeasure":"days per patient"}